Tag: post-market surveillance
Drug Interactions Discovered Post-Market: What It Means for Your Safety
Many dangerous drug interactions aren't found until after a medication is widely used. Learn how post-market surveillance catches hidden risks, why clinical trials miss them, and what you can do to protect yourself.
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA doesn't stop monitoring generic drugs after approval. Using systems like FAERS, Sentinel, and MedWatch, it tracks real-world safety issues, investigates manufacturing changes, and uses AI to catch hidden risks. Here's how it works.